Hims & Hers faces key FDA decisions on compounded GLP-1/semaglutide peptides—upside if permitted, downside if restricted.
Hims & Hers resolved its legal dispute with Novo Nordisk, removing a major overhang and enabling it to offer branded drugs. Valuations have not recovered to pre-lawsuit levels, as persistent insider ...
Hosted on MSN
Hims & Hers stock soars. Its weight-loss drug battle with Novo Nordisk takes a surprising twist
Hims & Hers Health has sparred with Novo Nordisk for months over the Danish drugmaker’s refusal to sell weight-loss drugs on its platform, but the bitter feud appears to have reached its end. Hims ...
Hims is a telehealth company offering discreet virtual consultations and prescription delivery for men's health concerns. Hims' hair loss program uses FDA-approved treatments like finasteride and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results